Venous Thromboembolism
Also known as: Venous Thrombo-embolism / Thromboembolism, Venous / Venous Thromboembolic Event / Venous thromboembolic events / Venous thromboembolisms / Venous Thromboembolism (VTE) / VTE (Venous Thromboembolism) / VTE / VTES / Acute embolism and thrombosis of unspecified vein / Venous embolism (disorder) / Venous embolism / Embolism venous / Venous embolism NOS
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00945 | Acetylsalicylic acid | A salicylate used to treat pain, fever, inflammation, migraines, and reducing the risk of major adverse cardiovascular events. |
| DB12364 | Betrixaban | A Factor Xa inhibitor used for prophylaxis of venous thromboembolism in hospitalized patients. |
| DB06695 | Dabigatran etexilate | An anticoagulant used for the prevention of venous thromboembolic events or stroke in patients with recent elective hip or knee replacement surgery and atrial fibrillation. |
| DB06779 | Dalteparin | A low molecular weight heparin used for the prophylaxis of thrombotic events in certain patients and prevent acute cardiac ischemic events in patients with unstable angina and non-Q-wave myocardial infarction. |
| DB08813 | Nadroparin | A low molecular weight heparin used for the prophylaxis of thrombotic events and deep vein thrombosis, and prevent unstable angina and non-Q-wave myocardial infarction. |
| DB06228 | Rivaroxaban | A factor Xa inhibitor used to treat deep vein thrombosis (DVT) and pulmonary embolism (PE). May also be used as thrombosis prophylaxis in specific situations. |
| DB06822 | Tinzaparin | A low molecular weight heparin used for the treatment of acute symptomatic deep vein thrombosis with or without pulmonary embolism when administered in conjunction with warfarin. |